BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 19771430)

  • 1. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells.
    Prados J; Melguizo C; Rama AR; Ortiz R; Segura A; Boulaiz H; Vélez C; Caba O; Ramos JL; Aránega A
    Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells.
    Rama AR; Prados J; Melguizo C; Burgos M; Alvarez PJ; Rodriguez-Serrano F; Ramos JL; Aranega A
    Biomed Pharmacother; 2011 Jul; 65(4):260-70. PubMed ID: 21723082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy using suicide gef gene and paclitaxel enhances growth inhibition of multicellular tumour spheroids of A-549 human lung cancer cells.
    Prados J; Melguizo C; Rama A; Ortiz R; Boulaiz H; Rodriguez-Serrano F; Caba O; Rodriguez-Herva JJ; Ramos JL; Aranega A
    Int J Oncol; 2008 Jul; 33(1):121-7. PubMed ID: 18575757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells.
    Ortiz R; Prados J; Melguizo C; Rama AR; Alvarez PJ; Rodríguez-Serrano F; Caba O; Boulaiz H; Aranega A
    Biomed Pharmacother; 2012 Oct; 66(7):563-7. PubMed ID: 22770988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of apoptosis and response of extracellular matrix proteins after chemotherapy application on human breast cancer cell spheroids.
    Oktem G; Vatansever S; Ayla S; Uysal A; Aktas S; Karabulut B; Bilir A
    Oncol Rep; 2006 Feb; 15(2):335-40. PubMed ID: 16391851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin.
    Boulaiz H; Aránega A; Cáceres B; Alvarez P; Serrano-Rodríguez F; Carrillo E; Melguizo C; Prados J
    BioDrugs; 2014 Feb; 28(1):63-74. PubMed ID: 23921576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
    Vadgama JV; Wu Y; Shen D; Hsia S; Block J
    Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7.
    Trebunova M; Laputkova G; Slaba E; Lacjakova K; Verebova A
    Anticancer Res; 2012 Jul; 32(7):2849-54. PubMed ID: 22753747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Ki-67 expression and morphological changes induced by gef gene in MCF-7 human breast cancer cells.
    Boulaiz H; Prados J; Marchal JA; Melguizo C; Concha A; Carrillo E; Vélez C; Martínez A; Aránega A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):87-92. PubMed ID: 16171567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells.
    Zeng S; Chen YZ; Fu L; Johnson KR; Fan W
    Clin Cancer Res; 2000 Sep; 6(9):3766-73. PubMed ID: 10999771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
    Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
    Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of taxane-induced cytotoxicity and apoptosis by gossypol in human breast cancer cell line MCF-7.
    Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Uslu R
    J BUON; 2009; 14(3):479-85. PubMed ID: 19810142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
    Greco O; Powell TM; Marples B; Joiner MC; Scott SD
    Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.
    Sakin V; Eskiocak U; Kars MD; Iseri OD; Gunduz U
    Exp Oncol; 2008 Sep; 30(3):202-5. PubMed ID: 18806742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
    Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.